Search research articles
Contact Us
Filters
Showing results (501-510 of 531) with videos related to
Page
of 54
Sort By:
Journal of Medicinal Chemistry
|
December 4, 2010
Synthesis and pharmacological evaluation of N-(3-(1H-indol-4-yl)-5-(2-methoxyisonicotinoyl)phenyl)methanesulfonamide (LP-261), a potent antimitotic agent
Rupa S Shetty, Younghee Lee, Bin Liu, et al.
European Urology
|
March 8, 2021
Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial
Thomas Powles, Michael B Atkins, Bernard Escudier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 14, 2022
Activation of a Latent Epitope Causing Differential Binding of Antineutrophil Cytoplasmic Antibodies to Proteinase 3
Marta Casal Moura, Gwen E Thompson, Darlene R Nelson, et al.
Annals of Internal Medicine
|
June 22, 2005
The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial
Jill P Buyon, Michelle A Petri, Mimi Y Kim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 28, 2020
Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma
Caroline Robert, Wen-Jen Hwu, Omid Hamid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 25, 2018
Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab
Richard W Joseph, Jeroen Elassaiss-Schaap, Richard Kefford, et al.
Food Microbiology
|
May 22, 2012
The evaluation of a PCR-based method for identification of Salmonella enterica serotypes from environmental samples and various food matrices
Junia Jean-Gilles Beaubrun, Chorng-Ming Cheng, Kai-Shun Chen, et al.
The New England Journal of Medicine
|
December 16, 2005
Combined oral contraceptives in women with systemic lupus erythematosus
Michelle Petri, Mimi Y Kim, Kenneth C Kalunian, et al.
Molecular Cancer Therapeutics
|
June 12, 2015
Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non-V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team
Patricia M LoRusso, Scott A Boerner, Mary Jo Pilat, et al.
Plos One
|
November 14, 2013
An integrated model of the transcriptome of HER2-positive breast cancer
Krishna R Kalari, Brian M Necela, Xiaojia Tang, et al.
Page
of 54
Search research articles
Search
Showing results (501-510 of 531) with videos related to
Sort By:
Page
of 54
Journal of Medicinal Chemistry
|
December 4, 2010
Synthesis and pharmacological evaluation of N-(3-(1H-indol-4-yl)-5-(2-methoxyisonicotinoyl)phenyl)methanesulfonamide (LP-261), a potent antimitotic agent
Rupa S Shetty, Younghee Lee, Bin Liu, et al.
European Urology
|
March 8, 2021
Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial
Thomas Powles, Michael B Atkins, Bernard Escudier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 14, 2022
Activation of a Latent Epitope Causing Differential Binding of Antineutrophil Cytoplasmic Antibodies to Proteinase 3
Marta Casal Moura, Gwen E Thompson, Darlene R Nelson, et al.
Annals of Internal Medicine
|
June 22, 2005
The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial
Jill P Buyon, Michelle A Petri, Mimi Y Kim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 28, 2020
Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma
Caroline Robert, Wen-Jen Hwu, Omid Hamid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 25, 2018
Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab
Richard W Joseph, Jeroen Elassaiss-Schaap, Richard Kefford, et al.
Food Microbiology
|
May 22, 2012
The evaluation of a PCR-based method for identification of Salmonella enterica serotypes from environmental samples and various food matrices
Junia Jean-Gilles Beaubrun, Chorng-Ming Cheng, Kai-Shun Chen, et al.
The New England Journal of Medicine
|
December 16, 2005
Combined oral contraceptives in women with systemic lupus erythematosus
Michelle Petri, Mimi Y Kim, Kenneth C Kalunian, et al.
Molecular Cancer Therapeutics
|
June 12, 2015
Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non-V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team
Patricia M LoRusso, Scott A Boerner, Mary Jo Pilat, et al.
Plos One
|
November 14, 2013
An integrated model of the transcriptome of HER2-positive breast cancer
Krishna R Kalari, Brian M Necela, Xiaojia Tang, et al.
Page
of 54